Literature DB >> 19647225

Raf-1 addiction in Ras-induced skin carcinogenesis.

Karin Ehrenreiter1, Florian Kern, Vanishree Velamoor, Katrin Meissl, Gergana Galabova-Kovacs, Maria Sibilia, Manuela Baccarini.   

Abstract

Ras activation is common to many human cancers and promotes cell proliferation and survival by initiating multiple signaling cascades. Accordingly, Ras-transformed cells are generally considered too resourceful to become addicted to a single effector. In contrast to this tenet, we now demonstrate an absolute, cell autonomous requirement for Raf-1 in the development and maintenance of Ras-induced skin epidermis tumors. Mechanistically, Raf-1 functions as an endogenous inhibitor dimming the activity of the Rho-dependent kinase Rok-alpha in the context of a Ras-induced Raf-1:Rok-alpha complex. Raf-1-induced Rok-alpha inhibition allows the phosphorylation of STAT3 and Myc expression and promotes dedifferentiation in Ras-induced tumors. These data link the Raf-1:Rok-alpha complex to STAT3/Myc activation and delineate a pathway crucial for cell fate decision in Ras-induced tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647225     DOI: 10.1016/j.ccr.2009.06.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  49 in total

1.  c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.

Authors:  Rafael B Blasco; Sarah Francoz; David Santamaría; Marta Cañamero; Pierre Dubus; Jean Charron; Manuela Baccarini; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-04-21       Impact factor: 31.743

2.  A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma.

Authors:  Eric A Collisson; Christy L Trejo; Jillian M Silva; Shenda Gu; James E Korkola; Laura M Heiser; Roch-Philippe Charles; Brian A Rabinovich; Byron Hann; David Dankort; Paul T Spellman; Wayne A Phillips; Joe W Gray; Martin McMahon
Journal:  Cancer Discov       Date:  2012-05-24       Impact factor: 39.397

Review 3.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

4.  New insight puts CRAF in sight as a therapeutic target.

Authors:  Ana Paula Rebocho; Richard Marais
Journal:  Cancer Discov       Date:  2011-07       Impact factor: 39.397

Review 5.  Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond.

Authors:  Matthew Holderfield; Marian M Deuker; Frank McCormick; Martin McMahon
Journal:  Nat Rev Cancer       Date:  2014-07       Impact factor: 60.716

6.  KRAS and YAP1 converge to regulate EMT and tumor survival.

Authors:  Diane D Shao; Wen Xue; Elsa B Krall; Arjun Bhutkar; Federica Piccioni; Xiaoxing Wang; Anna C Schinzel; Sabina Sood; Joseph Rosenbluh; Jong W Kim; Yaara Zwang; Thomas M Roberts; David E Root; Tyler Jacks; William C Hahn
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

7.  Targeting of Ras-mediated FGF signaling suppresses Pten-deficient skin tumor.

Authors:  Grinu Mathew; Abdul Hannan; Kristina Hertzler-Schaefer; Fen Wang; Gen-Sheng Feng; Jian Zhong; Jean J Zhao; Julian Downward; Xin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

8.  Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis.

Authors:  Xiaodong Ma; Munish Kumar; Saibyasachi N Choudhury; Lindsey E Becker Buscaglia; Juanita R Barker; Keerthy Kanakamedala; Mo-Fang Liu; Yong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

9.  Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.

Authors:  Mingliang He; Ming Luo; Qingyu Liu; Jingkao Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Leping Ouyang; Anmin Liu
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

10.  From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity.

Authors:  Théodora Niault; Izabela Sobczak; Katrin Meissl; Gregory Weitsman; Daniela Piazzolla; Gabriele Maurer; Florian Kern; Karin Ehrenreiter; Matthias Hamerl; Ismail Moarefi; Thomas Leung; Oliviero Carugo; Tony Ng; Manuela Baccarini
Journal:  J Cell Biol       Date:  2009-11-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.